X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13) 13
clinical trials (9) 9
male (9) 9
oncology (9) 9
hematology, oncology and palliative medicine (8) 8
aged (7) 7
middle aged (7) 7
cancer (6) 6
cancer therapies (6) 6
metastasis (6) 6
prostate cancer (6) 6
radiotherapy (6) 6
treatment outcome (6) 6
abridged index medicus (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
disease-free survival (5) 5
medicine, general & internal (5) 5
prostatic neoplasms - radiotherapy (5) 5
adult (4) 4
aged, 80 and over (4) 4
analysis (4) 4
care and treatment (4) 4
internal medicine (4) 4
medical prognosis (4) 4
prostatic neoplasms - drug therapy (4) 4
prostatic neoplasms - pathology (4) 4
quality of life (4) 4
quality-of-life (4) 4
radiation therapy (4) 4
radiation-therapy (4) 4
radical prostatectomy (4) 4
time factors (4) 4
androgen antagonists - therapeutic use (3) 3
androgen-deprivation therapy (3) 3
androgens (3) 3
bone neoplasms - drug therapy (3) 3
clinical-trials (3) 3
combined modality therapy (3) 3
disease progression (3) 3
female (3) 3
kaplan-meier estimate (3) 3
medical research (3) 3
men (3) 3
neoadjuvant therapy (3) 3
research (3) 3
risk factors (3) 3
survival analysis (3) 3
zoledronic acid (3) 3
androgen antagonists - administration & dosage (2) 2
androgen antagonists - adverse effects (2) 2
androgen suppression (2) 2
antineoplastic agents, hormonal - administration & dosage (2) 2
bisphosphonates (2) 2
bone neoplasms - secondary (2) 2
chemotherapy, adjuvant (2) 2
design (2) 2
diphosphonates - administration & dosage (2) 2
docetaxel (2) 2
drug administration schedule (2) 2
drug therapy (2) 2
estramustine (2) 2
evidence-based medicine (2) 2
external-beam radiotherapy (2) 2
follow-up studies (2) 2
gonadotropin-releasing hormone - agonists (2) 2
imidazoles - administration & dosage (2) 2
metastases (2) 2
neoplasm metastasis (2) 2
nuclear radiation (2) 2
oncology, experimental (2) 2
open-label (2) 2
orchiectomy (2) 2
ovarian-cancer (2) 2
patient outcomes (2) 2
patients (2) 2
proportional hazards models (2) 2
prostate (2) 2
prostatic neoplasms - mortality (2) 2
prostatic neoplasms - therapy (2) 2
radiotherapy - adverse effects (2) 2
randomized controlled trials as topic (2) 2
research design (2) 2
standard of care (2) 2
suppression (2) 2
survival (2) 2
survival rate (2) 2
taxoids - administration & dosage (2) 2
united kingdom (2) 2
1st 2 (1) 1
acid substitution variants (1) 1
acute myeloid-leukemia (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - radiotherapy (1) 1
adenocarcinoma - therapy (1) 1
administration, oral (1) 1
adolescent (1) 1
advanced osteogenic-sarcoma (1) 1
aged, aged, 80 and over, androgen antagonists, chemotherapy, adjuvant, disease progression, disease-free survival, dose fractionation, humans, intention to treat analysis, kallikreins, kaplan-meier estimate, male, middle aged, neoadjuvant therapy, neoplasm staging, proportional hazards models, prostate-specific antigen, prostatic neoplasms, radiotherapy, conformal, risk factors, time factors, treatment outcome (1) 1
androgen deprivation therapy (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10024, pp. 1163 - 1177
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10055, pp. 2004 - 2014
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 4, pp. 464 - 473
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9809, pp. 2104 - 2111
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 10, pp. 1396 - 1408
Journal Article